2014 annual financial data
Aptevo Therapeutics 2014 Net margin
Direct answer
Net margin was -112.02%.
Operating income was -51,492,000 USD and net income was -51,115,000 USD.
Operating cash flow was -47,007,000 USD.
Get free Aptevo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 45,631,000 USD
- Operating income
- -51,492,000 USD
- Net income
- -51,115,000 USD
- Operating cash flow
- -47,007,000 USD